Literature DB >> 12616133

Answering frequently asked questions about HPV.

Lisa K Gilbert1, Linda Alexander, Joanne F Grosshans, Leigh Jolley.   

Abstract

Mesh：

Year:  2003        PMID： 12616133     DOI： 10.1097/00007435-200303000-00002

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN： 0148-5717            Impact factor:   2.830


× No keyword cloud information.
  7 in total

1.  Characteristics Associated with HPV Diagnosis and Perceived Risk for Cervical Cancer Among Unmarried, Sexually Active College Women.

Authors:  Kelly L Wilson; Clayton J Cowart; Brittany L Rosen; Jairus C Pulczinski; Kayce D Solari; Marcia G Ory; Matthew Lee Smith
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

Review 2.  A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guide.

Authors:  Amy Chu; Eric Genden; Marshall Posner; Andrew Sikora
Journal:  Oncologist       Date:  2013-01-23

3.  Knowledge of human papillomavirus: differences by self-reported treatment for genital warts and sociodemographic characteristics.

Authors:  Jill Koshiol; Lila Finne Rutten; Richard P Moser; Nicola Hesse
Journal:  J Health Commun       Date:  2009-06

4.  What questions do people ask on a human papillomavirus website? A comparative analysis of public and private questions.

Authors:  Sung-Jong Lee; Hae-Jung Yun; Keun-Ho Lee; Chan-Joo Kim; Jong-Sup Park
Journal:  Int J Med Sci       Date:  2012-01-10       Impact factor: 3.738

5.  Making sense of information about HPV in cervical screening: a qualitative study.

Authors:  J Waller; K McCaffery; J Nazroo; J Wardle
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

6.  Discussing a diagnosis of human papillomavirus oropharyngeal cancer with patients: An exploratory qualitative study of health professionals.

Authors:  Rachael H Dodd; Laura A V Marlow; Jo Waller
Journal:  Head Neck       Date:  2015-05-22       Impact factor: 3.147

7.  Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasia.

Authors:  Misaki Wayengera
Journal:  Theor Biol Med Model       Date:  2012-07-28       Impact factor: 2.432
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.